ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A critical role of the endothelial S-phase kinase-associated protein 2/phosphatase and tensin homologue axis in angiogenesis and psoriasis

Xie, Xinya; Cui, Qi; Jiang, Tingting; Zhao, Ziwei; Liu, Zheyi; Liu, Jia; Yao, Qinyu; Wang, Yuxin; Dang, Erle; Wang, Gang; Xiao, Lei*; Wang, Nanping河北医科大学; 西安交通大学; 中国人民解放军第四军医大学
British Journal of Dermatology2024-1-23DOI: 10.1093/bjd/ljad399
1被引4阅读
引用收藏
分享

摘要

Background Psoriasis is a common chronic skin disorder. Pathologically, it features abnormal epidermal proliferation, infiltrating inflammatory cells and increased angiogenesis in the dermis. Aberrant expression of E3 ubiquitin ligase and a dysregulated protein ubiquitination system are implicated in the pathogenesis of psoriasis.Objectives To examine the potential role of S-phase kinase-associated protein 2 (Skp2), an E3 ligase and oncogene, in psoriasis.Methods Gene expression and protein levels were evaluated with quantitative reverse transcriptase polymerase chain reaction, Western blotting, immunohistochemistry and immunofluorescence staining of skin samples from patients with psoriasis vulgaris and an imiquimod (IMQ)-induced mouse model, as well as from cultured endothelial cells (ECs). Protein interaction, substrate ubiquitination and degradation were examined using co-immunoprecipitation, Western blotting and a cycloheximide chase assay in human umbilical vein ECs. Angiogenesis was measured in vitro using human dermal microvascular ECs (HDMECs) for BrdU incorporation, migration and tube formation. In vivo angiogenesis assays included chick embryonic chorioallantoic membrane, the Matrigel plug assay and quantification of vasculature in the mouse lesions. Skp2 gene global knockout (KO) mice and endothelial-specific conditional KO mice were used.Results Skp2 was increased in skin samples from patients with psoriasis and IMQ-induced mouse lesions. Immunofluorescent double staining indicated a close association of Skp2 expression with excessive vascularity in the lesional dermal papillae. In HDMECs, Skp2 overexpression was enhanced, whereas Skp2 knockdown inhibited EC proliferation, migration and tube-like structure formation. Mechanistically, phosphatase and tensin homologue (PTEN), which suppresses the phosphoinositide 3-kinase/Akt pathway, was identified to be a novel substrate for Skp2-mediated ubiquitination. A selective inhibitor of Skp2 (C1) or Skp2 small interfering RNA significantly reduced vascular endothelial growth factor-triggered PTEN ubiquitination and degradation. In addition, Skp2-mediated ubiquitination depended on the phosphorylation of PTEN by glycogen synthase kinase 3 beta. In the mouse model, Skp2 gene deficiency alleviated IMQ-induced psoriasis. Importantly, tamoxifen-induced endothelial-specific Skp2 KO mice developed significantly ameliorated psoriasis with diminished angiogenesis of papillae. Furthermore, topical use of the Skp2 inhibitor C1 effectively prevented the experimental psoriasis.Conclusions The Skp2/PTEN axis may play an important role in psoriasis-associated angiogenesis. Thus, targeting Skp2-driven angiogenesis may be a potential approach to treating psoriasis. @@@ In response to angiogenic vascular endothelial growth factor or imiquimod, Skp2 is induced in vascular endothelial cells to trigger PTEN for ubiquitination and degradation, resulting in excessive activation of the Akt pathway and aberrant angiogenesis. Targeting the Skp2/PTEN axis with small-molecule inhibitors attenuates angiogenesis and psoriasis.

学科与关键词

关键词
GROWTH-FACTORE3 LIGASESKP2PTENUBIQUITINATIONSKINPROMOTESVEGFPHOSPHORYLATIONINFLAMMATION
相关
加载中…
  • Inhibition of Skp2-driven angiogenesis attenuates imiquimod-induced psoriasis in mice
    Xiao, L.; Xie, X.; Cui, Q.; Jiang, T.; Wang, N.1st International Societies for Investigative Dermatology Meeting, Tokyo, JAPAN, 2023-05-12 To 2023-05-13.
  • Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression
    Tang, Lipeng; Zhang, Bowen; Li, Guanzhuo; Zhu, Ying; Feng, Bing; Su, Zuqing; Han, Wenhui; Huang, Huilin; Li, Qiuping; Wang, Maojie; Chen, Yuchao; Liu, Huazhen; Dai, Zhenhua; Wu, Dinghong; Li, Hongxia; Yang, Laijun; Lu, Yanjing; Ye, Zeting; Zheng, Guangjuan*Journal of Natural Medicines, 2023, 77(4): 712-720.被引 1
  • Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation
    Zhou, Jing; Bian, Huiying; Wu, Nan*JOURNAL OF DERMATOLOGY, 2023, 50(10): 1262-1271.
查看全部 →

发表信息

论文状态
公开发表
期刊
British Journal of Dermatology
发表日期
2024-01-23
卷期
第 190 卷, 第 2 期
页码
244-257
DOI
10.1093/bjd/ljad399
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81830015, 81770497, 82230012, 82070829]; National Key R&D Program of China [2018YFA0800600]; Natural Science Foundation of Shanghai [22ZR1418800]

作者

  • X

    Xie, Xinya (第一作者)

    xi an jiao tong univ

  • C

    Cui, Qi

    dalian med univ · inst med

查看全部 12 位作者收起作者
  • J

    Jiang, Tingting

    dalian med univ · inst med

  • Z

    Zhao, Ziwei

    dalian med univ · inst med

  • L

    Liu, Zheyi

    dalian med univ · inst med

  • L

    Liu, Jia

    xi an jiao tong univ

  • Y

    Yao, Qinyu

    xi an jiao tong univ

  • W

    Wang, Yuxin

  • D

    Dang, Erle

    fourth mil med univ

  • W

    Wang, Gang

    fourth mil med univ

  • X

    Xiao, Lei (通讯)

    xi an jiao tong univ

  • W

    Wang, Nanping

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417